David Wiseman

Title: David Wiseman: Innovator in Ophthalmic Drug Delivery

Introduction

David Wiseman is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of ophthalmic drug delivery, focusing on innovative formulations that enhance therapeutic efficacy. With a total of 3 patents to his name, Wiseman continues to push the boundaries of medical technology.

Latest Patents

Wiseman's latest patents include a groundbreaking ophthalmic drug sustained release formulation. This solid matrix sustained release formulation is designed for the topical delivery of a solid ophthalmic drug to the eye. It encompasses medical devices, drug cores, drug inserts, and drug delivery systems that utilize this formulation. The methods of manufacturing the formulation are also detailed, along with the medical devices and their methods for delivering the ophthalmic drug over a specified treatment period. The formulation is an admixture of an ophthalmic drug combined with a hydrophobic polymer, a hydrophilic polymer, and a surfactant. This innovative approach allows the drug to be eluted daily over an extended period at a therapeutic dose.

Career Highlights

David Wiseman is currently associated with Mati Therapeutics Inc., where he applies his expertise in drug formulation and delivery systems. His work is pivotal in advancing the field of ophthalmology, particularly in developing effective treatment options for patients.

Collaborations

Wiseman collaborates with talented professionals in his field, including Deepank Utkhede and Catherine Jones. Their combined efforts contribute to the innovative projects at Mati Therapeutics Inc.

Conclusion

David Wiseman stands out as a key figure in the realm of ophthalmic drug delivery innovations. His patents reflect a commitment to improving patient care through advanced medical technologies.